MetLife, Inc.
MET
$77.85
$0.260.34%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -7.10% | 11.93% | |||
| Total Other Revenue | 447.14% | -118.46% | |||
| Total Revenue | -0.50% | 1.20% | |||
| Cost of Revenue | -7.66% | 16.12% | |||
| Gross Profit | 26.02% | -31.41% | |||
| SG&A Expenses | -- | -- | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -0.23% | 3.09% | |||
| Total Operating Expenses | -6.37% | 13.62% | |||
| Operating Income | 119.40% | -68.69% | |||
| Income Before Tax | -1.96% | -30.74% | |||
| Income Tax Expenses | 281.13% | -83.77% | |||
| Earnings from Continuing Operations | -25.49% | -4.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -25.00% | -500.00% | |||
| Net Income | -25.65% | -5.29% | |||
| EBIT | 119.40% | -68.69% | |||
| EBITDA | 29.85% | -46.91% | |||
| EPS Basic | -27.94% | -1.94% | |||
| Normalized Basic EPS | -0.54% | -30.49% | |||
| EPS Diluted | -27.98% | -1.81% | |||
| Normalized Diluted EPS | -0.53% | -30.55% | |||
| Average Basic Shares Outstanding | -1.54% | -0.90% | |||
| Average Diluted Shares Outstanding | -1.56% | -0.82% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.44% | -0.04% | |||